Ignite Creation Date:
2025-12-24 @ 3:03 PM
Ignite Modification Date:
2025-12-26 @ 3:35 PM
Study NCT ID:
NCT01838759
Status:
COMPLETED
Last Update Posted:
2014-11-03
First Post:
2013-04-20
Is NOT Gene Therapy:
True
Has Adverse Events:
False
Brief Title:
Bioimpedance Spectroscopy for the Differential Diagnosis of Hyponatremia
Sponsor:
Zonguldak Bulent Ecevit University
Organization:
Study Overview
Official Title:
Bioimpedance Spectroscopy for the Differential Diagnosis of Hyponatremia
Status:
COMPLETED
Status Verified Date:
2014-10
Last Known Status:
None
Delayed Posting:
No
If Stopped, Why?:
Not Stopped
Has Expanded Access:
False
If Expanded Access, NCT#:
N/A
Has Expanded Access, NCT# Status:
N/A
Acronym:
None
Brief Summary:
We aimed to investigate the role of bioimpedance spectroscopy for the diagnosis of hyponatremia
Detailed Description:
* Up to now, "Hyponatremia" differentially diagnosed by physical examination, plasma and urine osmolalities, Echocardiography and biochemical measurements.
* The purpose of this study is to determine whether bioimpedance spectroscopy can be used for the detection of hypovolemia and hypervolemia for the differential diagnosis of hyponatremia.
* The purpose of this study is to determine whether bioimpedance spectroscopy can be used for the detection of hypovolemia and hypervolemia for the differential diagnosis of hyponatremia.
Study Oversight
Has Oversight DMC:
False
Is a FDA Regulated Drug?:
None
Is a FDA Regulated Device?:
None
Is an Unapproved Device?:
None
Is a PPSD?:
None
Is a US Export?:
None
Is an FDA AA801 Violation?: